These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10677044)

  • 1. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA.
    Schilling G; Wood JD; Duan K; Slunt HH; Gonzales V; Yamada M; Cooper JK; Margolis RL; Jenkins NA; Copeland NG; Takahashi H; Tsuji S; Price DL; Borchelt DR; Ross CA
    Neuron; 1999 Sep; 24(1):275-86. PubMed ID: 10677044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity.
    Nucifora FC; Ellerby LM; Wellington CL; Wood JD; Herring WJ; Sawa A; Hayden MR; Dawson VL; Dawson TM; Ross CA
    J Biol Chem; 2003 Apr; 278(15):13047-55. PubMed ID: 12464607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription.
    Wood JD; Nucifora FC; Duan K; Zhang C; Wang J; Kim Y; Schilling G; Sacchi N; Liu JM; Ross CA
    J Cell Biol; 2000 Sep; 150(5):939-48. PubMed ID: 10973986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamine pathogenesis.
    Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA.
    Ying M; Xu R; Wu X; Zhu H; Zhuang Y; Han M; Xu T
    J Biol Chem; 2006 May; 281(18):12580-6. PubMed ID: 16407196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophin-1 Function and Dysfunction in Dentatorubral-Pallidoluysian Atrophy.
    Nowak B; Kozlowska E; Pawlik W; Fiszer A
    Mov Disord; 2023 Apr; 38(4):526-536. PubMed ID: 36809552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological accumulation of atrophin-1 in dentatorubralpallidoluysian atrophy.
    Suzuki Y; Yazawa I
    Int J Clin Exp Pathol; 2011 Apr; 4(4):378-84. PubMed ID: 21577324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.
    Terashima T; Kawai H; Fujitani M; Maeda K; Yasuda H
    Neuroreport; 2002 Dec; 13(17):2359-64. PubMed ID: 12488827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dentatorubral-pallidoluysian atrophy.
    Tsuji S
    Handb Clin Neurol; 2012; 103():587-94. PubMed ID: 21827919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients.
    Sato T; Oyake M; Nakamura K; Nakao K; Fukusima Y; Onodera O; Igarashi S; Takano H; Kikugawa K; Ishida Y; Shimohata T; Koide R; Ikeuchi T; Tanaka H; Futamura N; Matsumura R; Takayanagi T; Tanaka F; Sobue G; Komure O; Takahashi M; Sano A; Ichikawa Y; Goto J; Kanazawa I
    Hum Mol Genet; 1999 Jan; 8(1):99-106. PubMed ID: 9887337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal deletion of the atrophin-1 protein results in growth retardation but not neurodegeneration in mice.
    Yu J; Ying M; Zhuang Y; Xu T; Han M; Wu X; Xu R
    Dev Dyn; 2009 Oct; 238(10):2471-8. PubMed ID: 19681162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic processing regulates pathological accumulation in dentatorubral-pallidoluysian atrophy.
    Suzuki Y; Nakayama K; Hashimoto N; Yazawa I
    FEBS J; 2010 Dec; 277(23):4873-87. PubMed ID: 20977674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
    Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
    Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DRPLA transgenic mouse substrains carrying single copy of full-length mutant human DRPLA gene with variable sizes of expanded CAG repeats exhibit CAG repeat length- and age-dependent changes in behavioral abnormalities and gene expression profiles.
    Suzuki K; Zhou J; Sato T; Takao K; Miyagawa T; Oyake M; Yamada M; Takahashi H; Takahashi Y; Goto J; Tsuji S
    Neurobiol Dis; 2012 May; 46(2):336-50. PubMed ID: 22342974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated expression of mutant DRPLA proteins with expanded polyglutamine stretches in neuronally differentiated PC12 cells. Preferential intranuclear aggregate formation and apoptosis.
    Sato A; Shimohata T; Koide R; Takano H; Sato T; Oyake M; Igarashi S; Tanaka K; Inuzuka T; Nawa H; Tsuji S
    Hum Mol Genet; 1999 Jun; 8(6):997-1006. PubMed ID: 10332031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA.
    Schilling G; Jinnah HA; Gonzales V; Coonfield ML; Kim Y; Wood JD; Price DL; Li XJ; Jenkins N; Copeland N; Moran T; Ross CA; Borchelt DR
    Neurobiol Dis; 2001 Jun; 8(3):405-18. PubMed ID: 11442350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.
    Luthi-Carter R; Strand AD; Hanson SA; Kooperberg C; Schilling G; La Spada AR; Merry DE; Young AB; Ross CA; Borchelt DR; Olson JM
    Hum Mol Genet; 2002 Aug; 11(17):1927-37. PubMed ID: 12165555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread occurrence of intranuclear atrophin-1 accumulation in the central nervous system neurons of patients with dentatorubral-pallidoluysian atrophy.
    Yamada M; Wood JD; Shimohata T; Hayashi S; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2001 Jan; 49(1):14-23. PubMed ID: 11198291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases.
    Yamada M; Sato T; Shimohata T; Hayashi S; Igarashi S; Tsuji S; Takahashi H
    Am J Pathol; 2001 Nov; 159(5):1785-95. PubMed ID: 11696439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CAG repeat size in the dentatorubral and pallidoluysian atrophy (DRPLA) gene in a normal population in Taiwan.
    Hsieh M; Chiu MH; Lin YH; Lin CH; Lu TM; Li SY; Li C
    Proc Natl Sci Counc Repub China B; 2000 Apr; 24(2):76-80. PubMed ID: 10809084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.